An open-label phase Ib study of ORIC-101 in combination with enzalutamide in patients with metastatic prostate cancer progressing on enzalutamide Meeting Abstract
| Authors: | Shore, N. D.; Efstathiou, E.; Patel, R.; Xu, R.; Johnson, A.; Multani, P. S.; Morris, M. J.; Abida, W. |
| Abstract Title: | An open-label phase Ib study of ORIC-101 in combination with enzalutamide in patients with metastatic prostate cancer progressing on enzalutamide |
| Meeting Title: | 2020 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2020 Feb 13-15 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-02-20 |
| Language: | English |
| ACCESSION: | WOS:000529525900006 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.6_suppl.TPS253 |
| Notes: | Meeting Abstract: TPS253 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work